Objectives:

  1. Discuss the history of neoadjuvant treatment for rectal cancer
  2. Discuss the benefits of non-operative management of rectal cancer
  3. Discuss the algorithm of watch and wait and the steps of active surveillance
Session date: 
03/27/2024 - 7:20am to 8:20am CDT
Location: 
Virtual/ HSLC 1335
United States
  • 1.00 AAPA Category 1 CME
  • 1.00 ABS Accredited CME
    • 1.00 ABS Self-Assessment
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™

Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Dana Hayden, MD